Home/Pipeline/PG-007

PG-007

Cell Culture / VEGFR2 Agonist

CommercialLaunched

Key Facts

Indication
Cell Culture / VEGFR2 Agonist
Phase
Commercial
Status
Launched
Company

About PeptiGrowth

Develops synthetic peptide alternatives to growth factors for xeno-free cell culture in regenerative medicine.

View full company profile

Therapeutic Areas